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Summary 
We have previously shown that the pancreatic cholecystokinin (CCK) receptor can 
be solubilized in 1% digitonin. In this study, digitonin-solubilized CCK receptors 
from rat pancreas were purified using sequential affinity chromatography on ricin-II 
agarose and on AffiGeI-CCK. Electrophoresis of the radioiodinated purified recep- 
tors on SDS-polyacrylamide gels followed by autoradiography revealed two proteins: 
a major band of Mr = 80,000-90,000, and a minor band of Mr = 55,000. Through the 
purification procedure, the receptors preserved their agonist specificity (CCK-8 < 
CCK-33 < desulfated CCK-8 < CCK-4) and binding affinity. Scatchard transfor- 
mations of binding data for the purified receptor preparation were best fit by linear 
plots compatible with a single class of binding sites with Ka = 9.4 nM. The estimated 
purification was about 80,000 fold and consistent with the expected Bmax for a pure 
Mr = 80,000 protein binding one CCK molecule. This two-step purification proce- 
dure opens the possibility for molecular studies of the CCK receptor. 
Cholecystokinin; Purification; Sequence determination 
Introduction 
Cholecystokinin (CCK) released from duodenal endocrine cells acts on a number 
of target organs including the exocrine and endocrine pancreas, gall bladder, and 
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stomach [1~4]. These peripheral actions of CCK are initiated by binding to a receptor 
whose binding affinity, agonist and antagonist specificity and pH optimum have been 
characterized [5-9]. These studies indicate that there is a peripheral CCK receptor 
which is distinct from both the central nervous system CCK receptor [10] and the 
peripheral gastrin receptor. Peripheral CCK receptors have been best studied on the 
pancreatic acinar cell where the binding subunit has an apparent molecular radius 
(Mr) of 76,000-95,000 as demonstrated by affinity labeling studies [11 15]. Further, 
the receptor is a glycoprotein based on affinity for lectins and susceptibility to en- 
doglycosidases [13,14,16]. Interpretation of these results is complicated, however, by 
the observation that different CCK receptor proteins appear to be labeled depending 
on the l/SI-labeled CCK probe used [16]. 
Further characterization of the CCK receptor therefore requires its purification 
and sequence determination. The initial step in this process was the demonstration 
that the receptor could be solubilized by use of the detergent digitonin with retention 
of ability to specifically bind CCK [17]. In the present report we have used the ability 
to solubilize the CCK receptor to develop a purification scheme involving lectin and 
CCK affinity chromatography. This procedure results in a preparation having a ma- 
jor protein band of Mr = 80,000-90,000 in SDS gel electrophoresis which specifically 
binds CCK. 
Materials and Methods 
Materials 
Pure natural porcine cholecystokinin (CCK-33) was obtained from Dr. V. Mutt, 
Karolinska Institute (Stockholm, Sweden). Synthetic CCK-8 and desulfated CCK-8 
(d-CCK-8) were gifts from the Squibb Institute for Medical Research (Princeton, 
N J). Soybean trypsin inhibitor (SBTI), benzamidine, bacitracin, phenylmethylsulfo- 
nyl fluoride (PMSF), HEPES, lactose, ethanolamine, human 7-globulin (HG-II) and 
urea were purchased from Sigma Chemical Co. (St. Louis, MO); bovine serum albu- 
min (BSA) fraction V from Miles Laboratories (Elkhart, IN); 125I-Bolton Hunter 
Reagent (2000 Ci/mmol) from New England Nuclear (Boston, MA); polyethylene 
glycol (PEG-6000), and digitonin (AnalaR) from BDH Chemicals Ltd. (Poole, U.K.); 
agarose bound lectins (wheat germ, ricin II, lentil, concanavalin A, peanut, and lotus) 
from E.Y. Laboratories, Inc. (San Mateo, CA); molecular weight standards for gel 
electrophoresis, and dithiothreitol (DTT) from Bio Rad Laboratories (Richmond, 
CA). Sprague-Dawley male rats, weighing 250-350 g, were killed by decapitation. 
Methods 
Solubilization of the CCK receptor. Routinely, pancreases from 32 rats were minced 
and homogenized by use of a Polytron homogenizer (Brinkmann Instruments, West- 
bury, NY) in 100 ml ice cold 'solubilization buffer' containing: 50 mM HEPES (pH 
7.4), 150 mM NaCI, 5 mM MgCI2, 1 mM EGTA, 1 mM benzamidine, and 0.1 mM 
PMSF, to which 1% (w/v) digitonin was added. Solubilization was carried out for 1 h 
at 4°C. Alternatively, plasma membranes prepared from isolated pancreatic acini as 
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described previously [18] were solubilized in the aforementioned "solubilization buff- 
er" with 1% digitonin for 1 h at 4°C in a glass test tube rotating 12 times per min, as 
described previously [17]. Protein concentrations, unless stated otherwise, were as- 
sayed by the Lowry method [19] using BSA as standard. 
All subsequent operations were also carried out at 4°C. The solubilized material 
was centrifuged at 110,000 g for 1 h, the supernatant collected, diluted to a final 
digitonin concentration of 0.5%, and used either for purification or directly stored 
frozen at - 70°C. 
Radioligand binding assay. CCK-33 was labeled with lz5I by conjugation with 
125I-Bolton Hunter reagent with a resulting spec. act. of 200-300 Ci/ktg; determina- 
tion of tracer CCK concentration was by bioassay employing rat or mouse pancreatic 
acini [20,21]. Binding experiments were performed in a total volume of 250 pl, as 
described previously [17]. Briefly, the incubation buffer consisted of 118 mM NaCI, 
4.7 mM KC1, 5 mM MgCI2, 1 mM EGTA, 5 mg/ml BSA, 1 mg/ml bacitracin, and 0.2 
mg/ml SBTI. Routinely, 50/A aliquots of solubilized material containing CCK recep- 
tors were incubated in a total volume of 250 pl with 50 pM 125I-CCK for 16 h at 40C 
and pH 6.5; CCK-8 was added at 1 #M to determine non-specific binding. Both total 
and non-specific binding were determined in duplicate tubes. After incubation, the 
receptor-CCK complex was precipitated by addition of an equal volume of 20% 
(w/v) PEG. Human y-globulin (final conc. 0.5 mg/ml) was present as carrier, and 
potassium iodide (final conc. 2.5 mg/ml) was added to reduce trapping of radio- 
activity. Samples were centrifuged at 2000 g for 30 min, the supernatants removed, 
and the pellets counted in a gamma-scintillation counter. Values are reported as the 
percent of added 125I-CCK which is specifically bound (i.e., total binding minus 
non-specific binding). Non-specific binding as in previous work [17] was essentially all 
accounted for by trapping of ~/sI-CCK in the PEG precipitated pellet and varied 
from 6 to 9% of added radioactivity. 
Affinity chromatography on agarose bound lectins. Lectins were equilibrated with 
'solubilization buffer' containing 0.5% digitonin. Samples of solubilized material 
were slowly passed through one of 6 different lectin-agarose columns: concanavalin 
A (Con A), lentil, peanut, lotus, wheat germ, and ricin II (RC-II). The columns were 
then washed, and the adsorbed material was eluted with the same buffer, containing 
specific haptenic inhibitors (sugars) at a concentration of 200 mM. Con A and lentil 
lectin were eluted with glucose, peanut lectin with galactose, lotus lectin with fucose, 
wheat germ with N-acetyl-D-glucosamine, and RC-II with lactose. Fractions were 
assayed for specific CCK binding. Peak fractions of partially purified receptors were 
stored at - 70°C. 
Affinity chromatography on AffiGel-CCK. Three mg of CCK-8 were dissolved at 1 
mg/ml in 50 mM borate, pH 9.3. Two ml of Affigel-15 were added and coupling was 
carried out in a 13 x 100 mm glass test tube rotating 3 times per min at 4°C for 6 h. 
The coupling was stopped by quenching with 10/A/ml of ethanolamine. AffiGel- 
CCK was then washed and equilibrated with 'solubilization buffer' plus 0.5% digito- 
nin. To assess efficiency, 100 #1 aliquots of the CCK-8 solution before and after 
coupling were diluted with 300 #1 of 50 mM borate, the pH was brought down to 1.9 
by adding 64/~1 of 1 N HC1, and concentrations of CCK-8 were assayed by measuring 
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OD2so, with D-CCK-8 as standard. Coupling efficiency was 34 ___ 6% (n = 3). Sub- 
sequently, AffiGel-CCK was incubated batchwise with 8 ml of the CCK receptor 
solution (partially purified on RC-II agarose) for 6 h at 4°C in a 13 x 100 mm glass 
test tube rotating 3 times per min. During this incubation, between 80 and 100% of 
specific CCK binding activity was routinely adsorbed by the AffiGeI-CCK. In control 
experiments, AffiGel alone quenched with ethanolamine did not adsorb any CCK 
binding activity. AffiGel-CCK-receptor complex was then washed 5 times by repeat- 
ed centrifugation and resuspension in 8 ml of'solubilization buffer' containing 0.5% 
digitonin, and finally eluted with 2.0 ml of 5 M urea in the same buffer. The eluted 
material was then dialyzed for 15 h against 3 x 200 ml of the digitonin containing 
'solubilization buffer' to remove urea, then assayed for specific CCK binding, and 
stored at - 70°C. 
Iodination, electrophoresis, and autoradiography. Purified receptors were iodinated 
by the chloramine T method [22]. Briefly, 200 #1 of pure receptor preparation, 20/~1 of 
chloramine T (0.4 mg/ml), and 200 #Ci 125I were incubated together at room temper- 
ature for 10 min. Free iodine was then separated from iodinated proteins on a Sepha- 
dex G-25 column. 
Samples were boiled in SDS sample buffer for 2 min in the presence of 50 mM 
DTT[12]. Electrophoresis was performed according to Laemmli [23], using 1.5 mm 
thick slab gels (12.5 × 16 cm) containing 7.5 % acrylamide. After electrophoresis, the 
gels were stained with the BioRad Silver Stain (Bio Rad Laboratories, Richmond, 
CA). The apparent molecular weight was calculated by using as standards: myosin 
(Mr = 200,000), fl-galactosidase (Mr = 116,250), phosphorylase-B (Mr = 92,500), bo- 
vine serum albumin (Mr = 45,000). Autoradiograms were obtained after exposure of 
the gels to Kodak X-Omat AR film with DuPont Cronex Lightning Plus enhancing 
screen at - 70°C. 
Results 
Partial purification of CCK receptors by lectin affinity chromatography 
Initially, pancreatic acini were prepared from the pancreases of 4 rats, and plasma 
membranes (routinely about 2 mg of protein) were purified by ultracentrifugation 
using sucrose gradients. The membranes were then solubilized at a concentration of 1 
mg of protein/ml with 1% digitonin (as described in Methods) yielding crude solu- 
bilized protein (550 _ 60/~g/ml mean + S.E.M., n= 3) with a specific 125I-CCK 
binding activity in our standard binding assay of 12 + 2% of total ligand added. 
Using this material the ability of 6 different agarose-bound lectins to adsorb CCK 
receptors was examined. All of these lectins adsorbed specific CCK binding activity 
(Fig. 1). However, only RC-II quantitatively adsorbed all of the CCK binding activ- 
ity; this binding activity was recovered in the lactose eluate (Fig. 1). Therefore, we 
selected RC-II as a tool in the further purification of the CCK receptors. 
In order to 'scale up' the preparation of solubilized receptors, the procedure was 
then simplified by omitting two steps: preparation of acini and isolation of acinar 
plasma membranes. Now, 32 rats were decapitated and whole pancreases were solu- 
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Fig. 1. Chromatography of the digitonin solubilized CCK receptors from purified rat pancreatic acinar 
membranes on individual lectin agarose columns. One ml portions of digitonin-solubilized membrane 
proteins were loaded on 2 ml bed volumes of lectins-agarose. Recovery of receptors was calculated from 
specific binding capacities in the standard ~25I-CCK binding assay. 
bilized (final volume of 100 ml) with 1% digitonin. After ultracentrifugation, 85 ml of 
supernatant could routinely be collected and this solubilized material showed specific 
CCK binding of approximately 1% of total ~ 25I-CCK in the standard binding assay. 
The solubilized material was then diluted to a final digitonin concentration of 0.5% 
and loaded on an RC-II agarose column of 25 ml bed volume (flow-rate: 0.5 ml/min). 
After adsorption, the column was washed with 'solubilization buffer' containing 
0.5% digitonin and finally, the semi-purified receptor fractions were eluted with 200 
mM lactose (Fig. 2). The fractions were then assayed for specific ~2sI-CCK binding. 
Affinity chromatography on RC-II column resulted in almost complete quantitative 
recovery of the CCK binding activity, which resulted in an approximately 400-fold 
purification of CCK receptors over the total homogenate (Table I). 
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Fig. 2. Purification of CCK receptors from solubilized rat pancreas on a RC-II-agarose column eluted with 
200 mM lactose. The lectin column (25 ml of settled gel) was loaded with digitonin-solubilized rat pancreas, 
washed with 40 ml of'receptor buffer', and then eluted with 30 ml of 200 mM lactose solution and collected 
as 2 ml fractions. 
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TABLE I 
Summary of purification of the CCK receptor from 32 whole rat pancreases 
Step Protein CCK binding activity Purification 
(mg) (fmol/mg) factor 
1. Solubilized pancreas 2,000 0.125 
2. RC-II chromatography 2.9 55 




The table quantitates a representative purification procedure. Specific CCK binding activities are based on 
the determinations of the amount of 12sI-CCK binding in our standard radioligand binding assay (see 
Methods). Since receptor affinity did not change with increasing grade of purity, this approach permits a 
good estimate of the relative purification at each step. 
Purification of CCK receptor by ligand affinity chromatography 
Peak f rac t ions  (4 x 2 ml)  f rom the R C - I I  co lumn  were then c o m b i n e d  and  ad-  
sorbed  on 2 ml o f  A f f i G e I - C C K  as descr ibed  in Methods .  The  A f f i G e l - C C K  ad-  
sorbed  80-100% o f  specific C C K  b ind ing  act ivi ty  f rom the R C - I I  purif ied mater ia l .  
A p p r o x i m a t e l y  30% o f  this a d s o r b e d  b ind ing  act ivi ty  was rout ine ly  recovered af ter  
e lut ion with urea  and  subsequent  dialysis .  The  p ro te in  con ten t  in the d ia lyzed  eluate  
was very low and  could  no t  be measured  accurate ly;  it d id  no t  exceed 1 #g/ml,  as 
es t imated  bo th  by p ro te in  assay and  the intensi ty  o f  silver s ta ining af ter  e lec t rophore-  
sis. Thus,  c h r o m a t o g r a p h y  on A f f i G e l - C C K  offered cons iderab le  fur ther  pur i f ica t ion  
o f  the C C K - r e c e p t o r  with a final pur i f ica t ion  o f  at  least  80,000 (Table  I). 
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Fig. 3. Analysis of receptor purity by radioiodination, SDS-polyacrylamide gel electrophoresis, and auto- 
radiography. Approximately 0.2 #g protein eluted from AffiGel-CCK-8 was iodinated with 1251 and free 
1251 was then removed on Sephadex G-25 column. The iodinated receptors (300,000 cpm) were boiled with 
50 mM DTT and electrophoresed on a 7.5% acrylamide gel. The figure shows a 12 h autoradiogram of the 
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Fig. 4. Inhibition of 125I-CCK binding to pancreatic CCK receptors purified on AffiGeI~CK by CCK 
analogues. Purified receptors were incubated with 50 pM ]25I-CCK for 16 h at 4°C and pH 6.5. Varying 
concentrations of analogs were added as shown. Non-saturable binding was subtracted from total binding, 
and saturable (specific) binding was expressed as the percent of maximal saturable binding. Maximal 
saturable binding was 4.6 + 0.7%. Values shown are the mean + S.E.M. of 3-5 experiments. 
The affinity-purified material was then radioiodinated and subjected to SDS/po- 
lyacrylamide gel electrophoresis and autoradiography. The highly purified receptor 
protein was found to consist of two protein bands: a major band with Mr of 80,000- 
90,000 and a very minor band with Mr of 55,000 (Fig. 3). 
Properties of purified CCK receptors 
The ability of 4 CCK analogs, CCK-8, CCK-33, d-CCK-8, and CCK-4, to inhibit 
125I.CC K binding to the purified receptor preparation was then examined. Competi- 
tion inhibition curves of specific 12 sI_CCK binding by unlabeled CCK-8 and CCK-33 
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Fig. 5. Scatchard plot of 12sI-CCK binding to pancreatic CCK receptors purified on AIIiGeI-CCK. Data 
are derived from a representative competitive binding experiment with CCK-33 under conditions specified 
in the legend to Fig. 4. The line is the computer fit specifying one class of binding sites with K a = 9.4 nM, 
and Bm~ , = 0.6 pmol/50/A. 
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nM for CCK-8 and 10 nM for CCK-33. Desulfated CCK-8 (d-CCK-8) was approxi- 
mately 1000-fold less potent an inhibitor of 125I-CCK binding than the sulfated form 
of CCK-8. CCK-4 had no effect at concentrations of up to 10/~M. Scatchard trans- 
formations of CCK-33 binding data (Fig. 5) were best fit by computer to linear plots 
compatible with a single class of binding sites with Ks = 9.4 + 0.7 nM (n = 3), and 
Bm,x = 0.6 + 0.07 pmol/50/d. 
Discussion 
In the present study we extended our previous observation that pancreatic CCK 
receptors could be solubilized with digitonin and that their ability to bind CCK could 
be retained [17]. In the present work we purified the receptor making use of two 
approaches. First purification of the receptor was followed and quantitated by bind- 
ing of 125I-CCK. Second, CCK covalently linked to a solid matrix was used for 
affinity purification of the CCK receptor. Using a two-step procedure involving im- 
mobilized lectin followed by ligand affinity chromatography, we purified the receptor 
to near homogeneity. Purification was approximately 80,000 fold and resulted in two 
identifiable protein bands under reducing conditions. 
Our previous study, in which affinity-labeled pancreatic CCK receptors adsorbed 
on Sepharoseqmmobilized wheat germ lectin, indicated that the receptor was a gly- 
coprotein containing either N-acetyl glucosamine and/or sialic acid residues [13]. In 
the present study, CCK binding activity was adsorbed and subsequently quantitative- 
ly recovered using another Sepharose-immobilized lectin, RC II. It is noteworthy that 
RC-II was twice as efficient in the purification of digitonin solubilized pancreatic 
CCK receptors than was wheat germ lectin. This observation suggests that the most 
predominant carbohydrate residue exposed in the receptor molecules is galactose 
rather than sialic acid. 
By coupling CCK-8 to AffiGel we further purified the CCK receptor. The RC-II- 
purified material was adsorbed on AffiGel-CCK and subsequently eluted with 5 M 
urea. After radioiodination of the receptor followed by SDS PAGE and autoradiog- 
raphy two proteins were identified. The Mr weights of the receptor, estimated by 
SDS-polyacrylamide gel electrophoresis, were 80,000-90,000 and 55,000, respectively 
(Fig. 3). Previous reports [11-13], employing covalent cross-linking techniques to 
study plasma membrane-bound receptors, suggested that the main binding domain of 
the pancreatic CCK receptor resided in an Mr = 76,000-85,000 glycoprotein. In addi- 
tion, another radiolabeled complex which migrated in SDS-polyacrylamide gel elec- 
trophoresis in position corresponding to an approximate Mr-- 55,000 has also been 
observed in some of these studies. Thus, apparent molecular weights of the receptor 
in the present study are in good accordance with the results of previous studies. The 
relation between the two CCK binding proteins remains to be further elucidated. The 
possibility that they constitute non-covalently associated subunits of a complex re- 
ceptor must be taken into consideration. However, another possibility is that the 
55,000 Mr protein is a degraded form of the larger molecule. 
The binding affinity and agonist specificity of the purified receptors were deter- 
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mined. These receptors showed specificity for CCK molecules with a relative potency 
of CCK-8 < CCK-33 < d-CCK-8 < CCK-4. These values are in accordance with 
data obtained with a variety of pancreatic receptor preparations including intact 
acinar cells [6], crude pancreatic membranes [7], purified acinar plasma membranes 
[17,24], and solubilized receptors [17]. Concentrations of the physiologically impor- 
tant CCK forms, CCK-8 and CCK-33, required to cause one half-maximal inhibition 
of 125I_CC K binding by the afffinity-purified receptors were almost indentical to those 
causing one half-maximal inhibition of 125I-CCK binding by solubilized receptors 
[15]. Apparently, once solubilized, CCK receptors preserved their agonist specificity 
and affinity throughout the entire purification procedure. Scatchard transformation 
of binding data to purified receptor yielded linear plots, indicating a single class of 
binding sites with Ka = 9.4 nM, and maximum binding capacity of 0.6 pmol/50 #1 in 
our standard binding assay. The protein concentration of the pure receptor prep- 
aration was estimated to be less than 1/~g/ml. Thus, maximum binding capacity of the 
purified receptor protein is at least 12 nmol/mg, a number close to that expected for a 
Mr = 80,000-90,000 receptor glycoprotein assuming a 1:1 binding stoichiometry. Un- 
certainties present in this analysis include the fact that migration of glycoproteins in 
SDS polyacrylamide gel electrophoresis often differs somewhat from their true mass 
and that an additional minor protein is also present. In a previous study [7], the Bmax 
of the CCK receptor in crude rat pancreatic membranes was approximately 0.5 pmol/ 
mg protein, i.e., some 30,000-fold lower than the Bmax of the purified receptors. Since 
our starting material in the present study is 3 times more "impure" than crude pan- 
creatic membranes (crude membrane preparations contain approximately 1/3 of total 
pancreatic protein), the degree of purification estimated in the present study by this 
evaluation is also approximately 90,000-fold. 
At present, the main limitation of this receptor purification scheme is the small 
amount of purified receptor protein obtained. This limitation makes accurate recep- 
tor quantitation impossible and does not allow studies of protein sequence. Future 
work will be directed, therefore, at increasing the yield of the purification process in 
order to provide more detailed information on the amino acid and sugar composition 
of the CCK receptor. 
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